SFI
XENT

Susquehanna Fundamental Investments’s Intersect ENT, Inc XENT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$816K Buy
29,138
+8,600
+42% +$236K 0.02% 911
2021
Q4 		$561K Sell
20,538
-4,450
-18% -$121K 0.01% 869
2021
Q3 		$680K Buy
24,988
+4,142
+20% +$102K 0.01% 1059
2021
Q2 		$356K Buy
+20,846
New +$390K 0.01% 1306

Other funds holding XENT

VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna Fundamental Investments's XENT Position: Q1 2022 in Review

Susquehanna Fundamental Investments increased its Intersect ENT, Inc (XENT) stake by 42% in Q1 2022, buying an estimated $236K and bringing the position to 29,138 shares worth $816K. The position accounts for 0.02% of the portfolio, ranked #911.

Susquehanna Fundamental Investments first reported a position in XENT in Q2 2021 and has held it in 4 quarters since. 131 funds tracked by Wall St. Rank hold XENT as of Q1 2022.

  • Susquehanna Fundamental Investments held 29,138 shares of Intersect ENT, Inc worth $816K as of Q1 2022.
  • Susquehanna Fundamental Investments bought 8,600 Intersect ENT, Inc shares in Q1 2022, an estimated $236K.
  • Intersect ENT, Inc made up 0.02% of Susquehanna Fundamental Investments's portfolio in Q1 2022, its #911 holding.
  • Susquehanna Fundamental Investments first reported a position in Intersect ENT, Inc in Q2 2021 and has held it in 4 quarters since.
  • 131 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2022.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2022, filed 16 May 2022.